Synthekine (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- September 17, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $82,000,000
Company Info
- Traction
- Lead programs have shown promising efficacy and tolerability in preclinical studies.
- Founders
- Debanjan Ray
- Company Description
- Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.
- Market
- Cytokine therapeutics for cancer and autoimmune disorders
- Location
- Menlo Park, California, USA
- Coinvestors
- Canaan Partners, Samsara BioCapital, The Column Group